Agonists of Peroxisome-Proliferator Activated Receptor-Gamma Reduce Renal Ischemia/Reperfusion Injury | Zendy

Ahila Sivarajah | Zendy; Prabal K. Chatterjee | Zendy; Nimesh S. A. Patel | Zendy; Zoran Todorović | Zendy; Yoshiyuki Hattori | Zendy; Paul A. Brown | Zendy; Keith N. Stewart | Zendy; Hélder MotaFilipe | Zendy; Salvatore Cuzzocrea | Zendy; Christoph Thiemermann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Agonists of Peroxisome-Proliferator Activated Receptor-Gamma Reduce Renal Ischemia/Reperfusion Injury

Author(s) -

Ahila Sivarajah,

Prabal K. Chatterjee,

Nimesh S. A. Patel,

Zoran Todorović,

Yoshiyuki Hattori,

Paul A. Brown,

Keith N. Stewart,

Hélder MotaFilipe,

Salvatore Cuzzocrea,

Christoph Thiemermann

Publication year - 2003

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000072088

Subject(s) - ciglitazone , rosiglitazone , endocrinology , medicine , kidney , peroxisome proliferator activated receptor , acute kidney injury , receptor

Recent evidence indicates that peroxisome-proliferator activated receptor (PPAR) agonists protect against ischemia/reperfusion (I/R) injury. Here we investigate the effects of the PPAR-gamma agonists, rosiglitazone and ciglitazone, on the renal dysfunction and injury caused by I/R of the rat kidney in vivo.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research